Albendazole vs Praziquantel for Neurocysticercosis Treatment
Author Information
Author(s): Matthaiou Dimitrios K., Panos Georgios, Adamidi Eleni S., Falagas Matthew E.
Primary Institution: Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece
Hypothesis
Is albendazole more effective than praziquantel in treating neurocysticercosis?
Conclusion
Albendazole is more effective than praziquantel in controlling seizures and leading to the total disappearance of cysts in patients with neurocysticercosis.
Supporting Evidence
- Albendazole was associated with better control of seizures than praziquantel.
- Albendazole led to a higher total disappearance of cysts compared to praziquantel.
- No significant difference was found in the reduction of cysts between the two treatments.
- Both treatments had similar rates of adverse events.
- The study included six trials with a total of 335 patients.
Takeaway
This study looked at two medicines for a brain infection caused by a parasite. It found that one medicine works better than the other in helping people feel better.
Methodology
A meta-analysis of six comparative trials was performed to evaluate the effectiveness and safety of albendazole versus praziquantel.
Potential Biases
Potential bias due to the small sample size and variability in treatment protocols.
Limitations
The small number of studies and patients limits the ability to draw definitive conclusions.
Participant Demographics
Patients with parenchymal neurocysticercosis, primarily from agricultural societies with poor sanitary conditions.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI 1.06–5.00
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website